Quarterly review covering the market outlook and summary of the latest quarter.
Quarterly review covering the market outlook and summary of the latest quarter.
Quarterly review covering the market outlook and summary of the latest quarter.
Quarterly review covering the market outlook and summary of the latest quarter.
In the second quarter of 2025, the Langdon Global Smaller Companies Portfolio delivered a return of 10.5%, a result driven by broad-based strength across several key holdings and regions. While we are pleased with the result, we remain focused not on quarter-to-quarter performance, but on investing in businesses with enduring economics and intelligent management.
Performance this quarter was led by industrials, technology, and healthcare. From a geographic standpoint, the UK, Germany, and Canada were the largest contributors to the portfolio’s return.
Industrials: Johns Lyng Group, a leading provider of insurance building restoration, commercial construction, and disaster recovery services, was a standout performer, but long-time readers will recall it had not been one of our better investments to date. Based in Australia, the company saw a material re-rating in its share price, climbing more than 40% over the quarter. We decided to increase our investment considerably in the quarter, and shortly after, they announced they were in discussion on a potential take-private situation. This was formalized after the end of the quarter, and we will have more to say on it between now and the shareholder vote in November. What appeared to be a materially negative contributor to fund returns at the end of the last quarter is now a meaningfully positive return since inception for the fund and nearly 100% return from our last material investment several months ago.
Technology: Agilysys, a software company serving the hospitality industry was the most significant contributor in the sector. They continue to benefit from as tructural modernization trend across the hospitality sector. Their software platform is becoming mission-critical for hotels and casinos that are upgrading property management systems. We believe Agilysysis still in the early innings of capturing wallet share globally. The combination of double-digit revenue growth and expanding margins is especially compelling given the predictable nature of its recurring revenue base.
Healthcare: In April, while Alex Simotas and Greg Dean were in Japan, Andlauer Healthcare Group announced its sale to UPS at a meaningful premium.The transaction reflected the strategic value of its healthcare logistics business and speaks to the quality of companies we look to originate from within Canada or any other region. UPS is a global healthcare logistics leader, and there was no way to build an Andlauer from scratch; the only way they could expand in Canada was to acquire them at a meaningful premium. The position made a meaningful contribution to fund performance during the quarter.
We exited our position in Auction Technology Group (ATG) this quarter. ATG operates one of the world’s leading marketplaces for online curated auctions, and while we continue to admire the company’s niche platforms, growth has moderated, and it is no longer clear to us that this is a business taking volume share in its end markets. We hold ourselves accountable to find companies that can grow free cash flow per share 10–15% over the medium term, as it is not enough to simply invest in cheap companies.
We believe three years is sufficient time to evidence market share gains and meaningful market growth. While we have seen increases in ATG’s take rate—driven more by pricing than volume through the adoption of seller services—we have not been able to prove to ourselves that the company is capturing a larger share of industry auction volumes. Our investment thesis relied on operating leverage and increased digitization in the art and antique auction space, both of which are now progressing at a more muted pace than we initially anticipated. After a period of underperformance, we determined that capital would be better deployed in management teams and businesses that are more clearly demonstrating their ability to take share when end markets are weak.
We continue to hold positions in Topicus.com, and CHAPTERS Group AG. These two companies are on similar missions at very different stages in their corporate lifecycles with Topicus many years if not decades further along. Both are building or running a decentralized,“buy-and-hold forever” model in the software industry and aiming to be strong homes for niche software businesses. Mansour Dia was in Germany right after quarter end to attend the CHAPTERS Group AGM and we will dive into more detail on this next quarter.
In our 2024 fourth quarter letter, we discussed Fever-Tree and how we felt the stock had dislocated from the fundamentals after several years of both the business and stock underperforming our expectations. Now, halfway through 2025, the stock is up 50% and is now delivering a pleasing return for our clients.
In our view, this is driven by their return to being an asset-lite brand owner, following their decision to complete a Joint Venture of their U.S. business with Molson Coors and hand over day-to-day operations to a much larger and more experienced company. Fever-Tree management can now focus their time and deploy shareholder capital toward higher-return areas such as new product development, point-of-sale activation, and brand marketing to drive long-term sell-through in the U.S. and globally.
We often say that our goal is not to “play the market,” but to own companies. That philosophy continues to serve us well. As prices fluctuate, we maintain the discipline to trim into strength and add where value presents itself, which, of late, has led to an increase in portfolio turnover. We believe not all turnover is bad and we have the tools and analytics to assess where turnover is adding value and when it is just driving up transaction costs and tax bills.
We currently see attractive opportunities in specialty insurance, industrial software, and asset-light services businesses in fragmented industries—particularly in continental Europe and the UK and are excited to continue to put capital to work.
Thank you for your continued support and trust.
This article is prepared by Langdon Equity Partners. Content in respect of the Langdon Smaller Companies Fund (ARSN 657 901 614 (the Fund) is issued by Pinnacle Fund Services Limited ABN 29 082 494 362 AFSL 238 371 (‘PFSL’) as responsible entity of the Fund. PFSL is not licensed to provide financial product advice. It contains general information only. It is not intended as a securities recommendation or statement of opinion intended to influence a person or persons in making a decision in relation to investment. It has been prepared without taking account of any person’s objectives, financial situation or needs. Any persons relying on this information should obtain professional advice before doing so.
Past performance is for illustrative purposes only and is not indicative of future performance.
While Langdon Equity Partners Limited (‘Langdon’) and PFSL believe the information contained in this communication is reliable, no warranty is given as to its accuracy, reliability or completeness and persons relying on this information do so at their own risk. Subject to any liability which cannot be excluded under the relevant laws, Langdon and PFSL disclaim all liability to any person relying on the information contained in this communication in respect of any loss or damage (including consequential loss or damage), however caused, which may be suffered or arise directly or indirectly in respect of such information. This disclaimer extends to any entity that may distribute this communication.
FOR AUSTRALIAN CLIENTS:
The Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the Fund are available via the links below. Any potential investor should consider the PDS and TMD before deciding whether to acquire, or continue to hold units in, the Fund.
Link to the Product Disclosure Statement: here
Link to the Target Market Determination: here
For historic TMD’s please contact Pinnacle Client Service Phone 1300 010 311 or Email service@pinnacleinvestment.com
FOR CANADIAN CLIENTS:
Important information about each Langdon mutual fund is contained in its prospectus, AIF, fund facts document and in its management report on fund performance. Any potential investor should review these documents prior to making any investment decision relating to such fund. You can view copies of these documents by following the links below:
Link to the Langdon Global Smaller Companies Portfolio Disclosure Documents: here
Link to the Langdon Canadian Smaller Companies Portfolio Disclosure Documents: here